mid, small cap companies, when I think about biotech, it is more about development stages, so to me, there are maybe five, distinct development stages, which is reflected by their valuation (broad strokes; there are always exceptions): ...
“One drug might work in another disorder, but it's not in the therapeutic area, so it will kind of languish. I saw similar things in other companies,” says Uden, who oversees Rallybio’s R&D. “But when you've got top-notch drug developers, you can look at a broad range and be...
” Scribe co-founder, president and CEO Benjamin Oakes, Ph.D., said in an emailed statement to Fierce. “This evolution necessitates business adjustments to allocate resources to where they are
"John is a guy who gets results and I have worked with him as both a client and a business customer. He breaks through the barriers of the convoluted HR process that sometimes seems designed to stagnate individuals’ career growth. He gets the right prospects to the right hiring managers an...
Hiring. This would seem to be a big one, especially in hotly competitive geographies such as Cambridge or the Bay Area. But now that more and more “virtual drug development” companies are filing for IPO in Phase 2 with staffs of fewer than fifteen people – two of these have beenCBT ...
CEO @ Avochato Angel investor View all testimonials Consulting, Tax and Valuation Prices Competitively priced for high-growth companies See our monthly pricing plans Financial Consulting Staff Accountant$120 Senior Staff Accountant$170 Controller$200 ...
businesses have been forced to re-think many longstanding systems that serve to perpetuate inequality in so many ways, which usually aren’t caught on cell phone video. Hiring, retention, and promotion are obvious places where companies have control, and a chance to make good on many stated ...
June 24 - G1 Therapeutics:Alongside news that Cosela had flunked a phase 3 breast cancer study, G1 announced that it would “discontinue the anticipated hiring of staff” that had been lined up to roll out the drug in that indication. In order to stick to its ambition...